Solid Biosciences Inc. connects with patients and stakeholders at 2026 annual Duchenne event

Solid Biosciences Inc. connects with patients and stakeholders at 2026 annual Duchenne event
Solid Biosciences Inc. at Duchenne event

Solid Biosciences Inc. participated in the 2026 ParentProjectMD Annual Conference, expressing gratitude for the opportunity to engage directly with patients, families, advocates, clinicians, and researchers within the Duchenne muscular dystrophy community.

The company used the event to strengthen ties with key stakeholders and demonstrate its commitment to addressing the needs of the Duchenne community. The gathering served as a collaborative platform for sharing insights, building relationships, and supporting ongoing research and advocacy efforts. Further details on outcomes or company announcements from the conference have yet to be disclosed.

Solid Biosciences previously announced plans to attend and sponsor the 2026 Parent Project Muscular Dystrophy Conference in Orlando. The company has also aimed to connect with genetic medicine partners at BIO2026 in San Diego. Both initiatives highlight its focus on platform collaborations and community engagement.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.